Physician profile
Andrew M Klausing
NPI 1528200482
$704.30
in general payments reported to CMS, 2019-2025
12 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $47.35 · 2023: $20.57 · 2024: $315 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289 · Travel and Lodging: $180 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.33 |
| Travel and Lodging | $179.56 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $250.78 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $140.26 | 2021-2025 | Dupixent |
| Genzyme Corporation | $67.49 | 2021-2023 | |
| Boston Scientific Corporation | $50.72 | 2024 | Watchman Flx |
| Medtronic, INC. | $37.24 | 2025 | Nim Vital |
| Acclarent, INC | $36.46 | 2021 | |
| Glaxosmithkline, LLC. | $33.10 | 2025 | Nucala |
| Optinose US, INC. | $27.82 | 2021-2024 | |
| Lilly USA, LLC | $17.75 | 2025 | Mounjaro, Zepbound |
| Stryker Corporation | $17.49 | 2022 | |
| Phadia US INC. | $13.77 | 2021 | |
| Kaleo, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Klausing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.